Congratulations to Zach Reitman, MD, PhD, who was awarded a $50,000 Spring 2024 Duke Cancer Institute Pilot Project grant for his proposal "Extremophile-derived radioprotectors to potentiate cell therapy."
The project aims to (1) characterize radioprotection conferred upon T cells by expression of extremophile-derived radioprotectant genes, and (2) execute a pooled genetic screen to prioritize genes that radioprotect T cells, with the goal of identifying genetic modifications that protect T cells during radiation therapy.